iPTH and Heart Failure: An Association
iPTH and Heart Failure: An Association
DOI:
https://doi.org/10.70284/njirm.v8i2.1218Keywords:
Heart Failure, iPTH, Cardiovascular diseaseAbstract
Background: Heart failure is a major public health burden. It is associated with considerable morbidity and mortality. There is a complex relationship between genetic, neuro hormonal, inflammatory and biochemical changes in the heart. High PTH level has been found to be associated with increased heart failure hospitalization. PTH has been shown to be an independent predictor of all cause and cardiovascular mortality in patients with heart failure. Strong correlation between high PTH level and advanced heart failure has been observed We tried to find out an association between iPTH and Heart Failure. Method: A pilot case control study involving 50 subjects (25 cases and 25 controls) have been done to identify the level of iPTH, 25 hydroxy vitamin D, serum phosphate and ionized calcium in heart failure patients. Serum iPTH and 25 hydroxy Vitamin D estimation was performed on Abbott Architect i1000 SR Analyzer using enhanced chemiluminescent immunoassay technique. Serum creatinine, phosphate and alkaline phosphatase were analyzed on fully automated analyzer AU480 from Beckmann Coulter using spectrophotometric technique. Statistical Analysis has been done by SPSS. Results: The level of iPTH, phosphorous and calcium significantly varied among both the groups (case and control); p value is less than 0.05. Interpretation and Conclusion: In our study it has been found that iPTH level is high in heart failure cases compared to controls which are statistically highly significant. Therefore the study indicates a strong association of iPTH and heart failure. [Anupa P NJIRM 2017; 8(2):123-125]
References
2. Sugimoto T, Tanigawa T, Onishi K, Fujimoto N, Matsuda A, Nakamori S, Matsuoka K, Nakamura T, Koji T, Ito M. Serum intact parathyroid hormone levels predict hospitalisation for heart failure. Heart. 2009 Mar 1;95(5):395-8..
3. van Ballegooijen AJ, Reinders I, Visser M, Brouwer IA. Parathyroid hormone and cardiovascular disease events: a systematic review and meta-analysis of prospective studies. American heart journal. 2013 May 31;165(5):655-64.
4. Altay H, Colkesen Y. Parathyroid hormone and heart failure: Novel biomarker strategy. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders). 2013 Mar 1;13(1):100-4.
5. Altay H, Zorlu A, Bilgi M, Erol T, Yilmaz MB. Usefulness of parathyroid hormone as a predictor of heart failure with preserved ejection fraction. Biomarkers. 2012 Aug 1;17(5):447-54.
6. Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, Lappé DL, Muhlestein JB, Group IH. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. The American journal of cardiology. 2010 Oct 1; 106(7):963-8.
7. Thomas GN, ó Hartaigh B, Bosch JA, Pilz S, Loerbroks A, Kleber ME, Fischer JE, Grammer TB, Böhm BO, März W. Vitamin D Levels Predict All-Cause and Cardiovascular Disease Mortality in Subjects With the Metabolic Syndrome The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Diabetes Care. 2012 May 1;35(5):1158-64.
8. Kestenbaum B, Katz R, de Boer I, Hoofnagle A, Sarnak MJ, Shlipak MG, Jenny NS, Siscovick DS. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. Journal of the American College of Cardiology. 2011 Sep 27;58(14):1433-41.
9. Wannamethee SG, Welsh P, Papacosta O, Lennon L, Whincup PH, Sattar N. Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circulation: Heart Failure. 2014 Sep 1;7(5):732-9.
